AIDS Weekly articles from September 2002

AIDS Weekly archives from September 2002

Drug eruption study yields surprising results.(drug allergy study)
September 2, 2002... 2002 SEP 2 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in France have shed new light on the inflammatory drug reactions often seen in HIV patients. "Persons with HIV infection have increased rates of...

Short-course nevirapine doesn't improve standard preventive therapy.
September 2, 2002... 2002 SEP 2 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Short-course nevirapine therapy doesn't help prevent vertical HIV transmission from women with access to standard treatment regimens, researchers argue. "A...

UCSD study shows increased transmission of drug-resistant HIV infection.
September 2, 2002... 2002 SEP 2 - (NewsRx.com & NewsRx.net) -- An increase in the transmission rate of drug-resistant HIV, now affecting as many as one in five newly infected people, has been discovered by researchers at the University of California, San Diego...

Viral Nef protein triggers podocyte growth and proliferation.(of HIV-associated nephropathy)
September 2, 2002... 2002 SEP 2 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - The HIV Nef protein appears to be involved in the development of HIV-associated nephropathy (HIVAN), researchers say. "HIV-1 infection induces the loss of...

Novel technique enables single-cell latency analysis.
September 2, 2002... 2002 SEP 2 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in the United States have developed a novel technique for studying latent HIV infection. "The ability of human immunodeficiency virus type 1...

T-20 administration has little impact on daily activities of patients after 8 weeks of treatment.
September 2, 2002... 2002 SEP 2 - (NewsRx.com & NewsRx.net) -- Roche and Trimeris, Inc., (TRMS) announced that data collected from a survey of patients in two large, internationally conducted phase III trials suggest that subcutaneous delivery of T-20 was...

Vietnam reports 9000 new people detected as HIV-positive.(Brief Article)
September 2, 2002... 2002 SEP 2 - (NewsRx.com & NewsRx.net) -- Just over 9000 new cases of HIV infection were logged in Vietnam during the first 7 months of this year, bringing the total number of HIV carriers in the country to more than 50,000, official media...

Young people account for 40% of HIV-infected in Japan.
September 2, 2002... 2002 SEP 2 - (NewsRx.com & NewsRx.net) -- People in their teens and 20s account for nearly 40% of all Japanese newly infected with the AIDS virus, according to new Health Ministry figures that officials say underline a disturbing new trend. ...

Once-daily HIV Medications pave way for simplified combination drug regimens.(Brief Article)
September 2, 2002... 2002 SEP 2 - (NewsRx.com & NewsRx.net) -- A once-daily drug regimen comprising three leading anti-HIV medications may allow HIV patients, who previously followed complicated, multidose drug regimens, to create a once-daily combination therapy...

Panacos unveils the leading compound in a new class of HIV drug candidates: budding inhibitors.(Panacos Pharmaceuticals Inc.)(Brief Article)
September 2, 2002... 2002 SEP 2 - (NewsRx.com & NewsRx.net) -- Panacos Pharmaceuticals, Inc., made its first public presentation on the company's HIV drug candidate, PA-457, at the XIV International AIDS Conference in Barcelona, Spain. PA-457 is the first in a...

Roche, Trimeris announce next steps in bringing Fuzeon (T-20) to HIV patients.(Brief Article)
September 2, 2002... 2002 SEP 2 - (NewsRx.com & NewsRx.net) -- Results from Fuzeon (T-20) phase III studies, reported at the International AIDS Conference in Barcelona, showed greater than expected benefit in the patient population studied. In addition, the...

Sarawak initiates clinical trial of Calanolide A in combination therapy for HIV.(Sarawak MediChem Pharmaceuticals Inc.)(Brief Article)
September 2, 2002... 2002 SEP 2 - (NewsRx.com & NewsRx.net) -- Sarawak MediChem Pharmaceuticals, Inc., announced that it has begun screening volunteers for a 48 subject, clinical trial of Calanolide A in combination therapy for HIV. This clinical trial will...

Serono announces significant results from two clinical trials of Serostim.(Brief Article)
September 2, 2002... 2002 SEP 2 - (NewsRx.com & NewsRx.net) -- Serono S.A. (SRA) announced positive results of two major clinical trials of Serostim [somatropin (rDNA origin) for injection] for the treatment of AIDS-related metabolic complications at the XIV...

Sustiva provides immunosuppressed HIV/AIDS patients effective treatment alternative.
September 2, 2002... 2002 SEP 2 - (NewsRx.com & NewsRx.net) -- Data presented at the XIV International AIDS Conference show that a greater proportion of patients on highly active antiretroviral therapy (HAART) containing Sustiva (efavirenz), Bristol-Myers Squibb's...

FDA advisers plug new drug.(adefovir from Gilead Sciences Inc. for the treatment of hepatitis B)
September 2, 2002... 2002 SEP 2 - (NewsRx.com & NewsRx.net) -- A failed HIV therapy should be sold instead to treat the liver-destroying hepatitis B virus, advisers to the U.S. Food and Drug Administration have ruled. If the FDA agrees, Gilead Sciences'...

The Immune Response Corp. announces proposed private offering of common stock and warrants.(Brief Article)
September 2, 2002... 2002 SEP 2 - (NewsRx.com & NewsRx.net) -- The Immune Response Corp. (MNR) announced it is seeking to raise, subject to market and other conditions, up to $8 million in gross proceeds ($10.4 million if the 30% overallotment option is exercised)...

Texas medical center recalls body parts that were not tested for HIV, other infections.(University of Texas Medical Branch)
September 2, 2002... 2002 SEP 2 - (NewsRx.com & NewsRx.net) -- A medical center whose handling of cadavers has come under FBI investigation said August 6, 2002, that it is recalling body parts sent to research institutions around the country, warning they may carry...

Gender, AIDS status do not affect isoniazid levels.
September 2, 2002... 2002 SEP 2 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in the United States have shed new light on the pharmacokinetics of a popular antituberculosis agent. John E. Conte Jr. and colleagues at the...

Alcohol use, thrill-seeking prove bad mix for HIV-positive men.
September 9, 2002... 2002 SEP 9 - (NewsRx.com & NewsRx.net) -- HIV-positive men who seek new experiences and think alcohol improves sex are more likely to have unprotected sex, according to a new study. Most HIV prevention programs target risk-takers who are...

Hip osteonecrosis incidence may be rising.
September 9, 2002... 2002 SEP 9 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Necrotic degeneration of hip bones is becoming increasingly common in patients infected with HIV, researchers warn. "Osteonecrosis has been reported to...

Hepatitis C, Epstein-Barr virus interactions have little impact on lymphoma risk.
September 9, 2002... 2002 SEP 9 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Interactions between hepatitis C and Epstein-Barr viruses have little effect on the risk of non-Hodgkin lymphoma in HIV patients, researchers in France argue....

Novel nucleic acid tests suitable for large-scale HIV, hepatitis C blood donor screening.
September 9, 2002... 2002 SEP 9 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in the United States have developed a highly sensitive assay system for finding HIV or hepatitis C infection in blood. "Various nucleic acid...

Low-dose paclitaxel effective for high-risk Kaposi sarcoma patients.
September 9, 2002... 2002 SEP 9 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Paclitaxel therapy can help patients suffering from refractory Kaposi sarcoma, according to researchers in the United States. "Treatment options are...

ACTG Clinical Trial: Remune alone stimulated stronger immune responses.(AIDS Clinical Trials Group )
September 9, 2002... 2002 SEP 9 - (NewsRx.com & NewsRx.net) -- The Immune Response Corp. (IMNR) announced that the Adult AIDS Clinical Trials Group of the National Institutes of Health presented new data at the XIV International AIDS Conference from a clinical...

New compound may immobilize AIDS virus, certain radionuclides.(niobium heteropolyanions )
September 9, 2002... 2002 SEP 9 - (NewsRx.com & NewsRx.net) -- A compound that could potentially immobilize the AIDS virus or selectively extract radionuclides from nuclear wastes at various U.S. high-level storage sites has been developed by a researcher at Sandia...

MedImmune announces three new executives.(Brief Article)
September 9, 2002... 2002 SEP 9 - (NewsRx.com & NewsRx.net) -- MedImmune, Inc., (MEDI) announced the appointment of Pamela J. Lupien as vice president, human resources, Edward T. Mathers as vice president, corporate development, and Lota S. Zoth as vice president...

SurgiLance renews contract with Professional HealthSales.
September 9, 2002... 2002 SEP 9 - (NewsRx.com & NewsRx.net) -- SurgiLance, Inc., has renewed an annual agreement with Professional HealthSales, Inc., (PHS) of Perkasie, Pennsylvania, in which PHS and its team of 30 representatives will continue to be SurgiLance's...

Study shows promise for identifying lead compounds.
September 9, 2002... 2002 SEP 9 - (NewsRx.com & NewsRx.net) -- A recent study published in Nature Biotechnology has demonstrated a new method for identifying lead compounds for drug discovery. The method described in the study is based on technology developed...

VaxGen releases second-quarter results; development expenses met expectations.
September 9, 2002... 2002 SEP 9 - (NewsRx.com & NewsRx.net) -- VaxGen, Inc., (VXGN) announced a net loss of $6.7 million, or 46 cents per share excluding noncash charges, for the second quarter ended June 30, 2002, compared with a net loss of $5.9 million, or 42...

CDC visit to San Francisco probes workshops.(U.S. Centers for Disease Control and Prevention evaluates California city's public health program)
September 9, 2002... 2002 SEP 9 - (NewsRx.com & NewsRx.net) -- Federal officials met with members of San Francisco's public health department August 13, 2002, to try to determine whether HIV prevention workshops such as "A Walk on the Wildside" and "Guy Watch" are...

California representatives cross party lines to back increase for AIDS drugs.
September 9, 2002... 2002 SEP 9 - (NewsRx.com & NewsRx.net) -- California's representatives in Congress joined across party lines to ask House of Representatives leadership to end waiting lists for AIDS drugs by increasing funds for treatment. "With over 1200...

Patients with bleeding disorder face liver disease from bloodborne pathogens.
September 9, 2002... 2002 SEP 9 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - The cumulative incidence of hepatitis C virus (HCV)-related end-stage liver disease in patients with hemophilia increases with human immunodeficiency virus...

Human herpesvirus-8 infection common in south Texas children.
September 9, 2002... 2002 SEP 9 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Young children in south Texas have a surprisingly high risk of infection with a cancer-causing virus, researchers warn. "Human herpesvirus 8 (HHV-8), also...

AIDS activists threaten legal action if government rejects critical AIDS drug.(nevirapine )
September 9, 2002... 2002 SEP 9 - (NewsRx.com & NewsRx.net) -- AIDS activists have threatened to sue the South African body that regulates medicines if it withdraws its approval of a drug used to help stop the spread of HIV from pregnant women to their babies. ...

Elizabeth Glaser Pediatric AIDS Foundation awarded $100M.
September 9, 2002... 2002 SEP 9 - (NewsRx.com & NewsRx.net) -- The Elizabeth Glaser Pediatric AIDS Foundation announced that the United States Agency for International Development (USAID) has awarded a grant of up to $100 million over 5 years to the Foundation's...

De Beers becomes latest company to make AIDS drugs available to its employees.(Brief Article)
September 9, 2002... 2002 SEP 9 - (NewsRx.com & NewsRx.net) -- With a swipe at South Africa's often-criticized AIDS policy, diamond giant De Beers announced August 12, 2002, it would heavily subsidize the cost of AIDS medicine for its employees. The...

RNA interference could be effective treatment strategy.
September 16, 2002... 2002 SEP 16 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in the United States have identified a novel and promising treatment modality against HIV infection. "Synthetic small interfering RNAs (siRNAs)...

Genotyping less effective at predicting effective regimens in children.
September 16, 2002... 2002 SEP 16 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - A commonly used method of determining appropriate HIV treatment for adults may not work as well for pediatric HIV patients, researchers in the United States...

Promising multistrain HIV vaccine candidate emerges.
September 16, 2002... 2002 SEP 16 - (NewsRx.com & NewsRx.net) -- AIDS researchers have developed a candidate vaccine strategy that, for the first time, demonstrates an ability to elicit antibodies that block the infection of multiple HIV virus strains - an elusive...

Substance P blocker can prevent viral replication.(HIV replication)
September 16, 2002... 2002 SEP 16 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in the United States have identified a novel agent that shows promise as a treatment for HIV and other viral infections. "Substance P (SP), a...

T-20 safe, effective for pediatric use.(HIV treatment for children)
September 16, 2002... 2002 SEP 16 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - The novel anti-HIV agent T-20 is safe and effective for use with infected children, researchers in the United States say. "Entry inhibitors, a new class...

Twenty years of monkey research boosts AIDS knowledge.
September 16, 2002... 2002 SEP 16 - (NewsRx.com & NewsRx.net) -- Research on an AIDS-like disease in monkeys continues to help scientists understand problems such as how HIV causes AIDS, how the virus "hides" from the immune system and how the disease might be...

HIV targets active genes in cells.
September 16, 2002... 2002 SEP 16 - (NewsRx.com & NewsRx.net) -- HIV selectively inserts itself into active areas of a host cell's genome, Salk Institute researchers have found for the first time. The fact that the virus hooks itself up to areas of the cell's...

New drug raises hopes, fears.(Fuzeon fusion inhibitor for HIV treatment)
September 16, 2002... 2002 SEP 16 - (NewsRx.com & NewsRx.net) -- The U.S. government has approved tests of an experimental and potentially expensive AIDS drug that could prolong the lives of patients with drug-resistant strains of HIV. Dubbed Fuzeon by its...

The Immune Response Corp. announces results from Remune trial.
September 16, 2002... 2002 SEP 16 - (NewsRx.com & NewsRx.net) -- Indicating for the first time in a clinical trial that Remune might give relief for HIV-infected patients from the adverse side-effects of antiretroviral therapies, The Immune Response Corp. (IMNR)...

Groundbreaking approach to prevent transmission of HIV shows promise.(microbicides )
September 16, 2002... 2002 SEP 16 - (NewsRx.com & NewsRx.net) -- New, anti-infective substances that can be developed as gels, creams, foams, films, even impregnated sponges and suppositories may prove to be a ground-breaking approach to preventing the spread of...

Calypte receives initial order for urine HIV tests from West Africa.(Calypte Biomedical Corp. )
September 16, 2002... 2002 SEP 16 - (NewsRx.com & NewsRx.net) -- Calypte Biomedical Corporation (CALY), the developer and marketer of the only two FDA-approved HIV-1 Antibody tests that can be used on urine samples announced that it has received its first West...

Hepatitis worse during immunocompetence with HIV/hepatitis C coinfection.
September 16, 2002... 2002 SEP 16 - (NewsRx.com & NewsRx.net) -- by Sonia Nichols, senior medical writer - Ironically, liver disease may worsen when there is immunocompetence in hemophiliacs coinfected with human immunodeficiency virus (HIV) and hepatitis C virus...

Roche Molecular initiates trials of Cobas AmpliScreen HBV test.(hepatitis B test)
September 16, 2002... 2002 SEP 16 - (NewsRx.com & NewsRx.net) -- Roche Molecular Systems, Inc., (Roche) announced the start of comprehensive clinical trials of its Cobas AmpliScreen HBV test. The trials mark an important milestone because, for the first time in...

Group wins $127M for global health communication project.
September 16, 2002... 2002 SEP 16 - (NewsRx.com & NewsRx.net) -- A group led by the Johns Hopkins University Center for Communication Programs (JHU/CCP) has been awarded $127 million by the U.S. government to implement a 5-year global project designed to use...

Liquid efavirenz safe, effective for children.(with HIV infection)
September 16, 2002... 2002 SEP 16 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - A liquid version of the powerful antiretroviral agent efavirenz is safe and effective for pediatric use, researchers say. Stuart E. Starr and colleagues...

Head of World Summit: Development progress impossible without tackling AIDS.
September 16, 2002... 2002 SEP 16 - (NewsRx.com & NewsRx.net) -- Progress in global development is impossible without tackling the AIDS pandemic, the head of the World Summit said August 25, 2002. Fighting the disease is a major objective of the 10-day gathering...

Controversial rapid screen effective after occupational exposure.
September 23, 2002... 2002 SEP 23 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - A controversial rapid HIV test can be effectively used to screen for infection after occupational exposure, researchers in Virginia argue. "The Single Use...

Arginine treatment may improve immune function.
September 23, 2002... 2002 SEP 23 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Treatment with the nonessential amino acid arginine may improve immune function in HIV patients, researchers in the United States report. Dr. Barbara...

Significantly improved survival in intensive care seen for HIV patients.
September 23, 2002... 2002 SEP 23 - (NewsRx.com & NewsRx.net) -- A patient infected with human immunodeficiency virus (HIV) who is admitted to the intensive care unit (ICU) in this era of highly active antiretroviral therapy has a markedly improved survival rate,...

Lopinavir and ritonavir superior to nelfinavir-based regimens.
September 23, 2002... 2002 SEP 23 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - A group of researchers have shed new light on the relative efficacies of several antiretroviral agents used to treat HIV infection. "Lopinavir is a newly...

Murabatide safely improves immune response to infection.
September 23, 2002... 2002 SEP 23 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - A novel agent can greatly enhance the immune response to HIV infection, researchers in France say. "The safe synthetic immunomodulator Murabutide (ISTAC...

Cosmetic surgery can restore facial appearance.
September 23, 2002... 2002 SEP 23 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Cosmetic surgery can be used to flesh out the gaunt appearance associated with HIV lipodystrophy, researchers say. "The use of highly active antiretroviral...

Manufacturer says Chinese version of anti-AIDS drug to reach patients by end of year.(Brief Article)
September 23, 2002... 2002 SEP 23 - (NewsRx.com & NewsRx.net) -- A generic version of the anti-AIDS drug AZT will be available in China before the end of the year as a low-cost alternative to pricey imported medicines, the manufacturer said August 16, 2002. ...

Norzyme awarded grant by National Institutes of Health.
September 23, 2002... 2002 SEP 23 - (NewsRx.com & NewsRx.net) -- Norzyme, Inc., developers of in vitro diagnostic technology for therapeutic drug monitoring, announced the National Institutes of Health (NIH) has further recognized the promise of its Levoprin-ZG...

Orathecin receives orphan-drug designation for treatment of pediatric AIDS.(Brief Article)
September 23, 2002... 2002 SEP 23 - (NewsRx.com & NewsRx.net) -- SuperGen, Inc., (SUPG) announced that its oral anticancer cancer compound Orathecin has received orphan-drug designation from the U.S. Food and Drug Administration (FDA) for the treatment of pediatric...

Roche and Trimeris open physician enrollment for Fuzeon early access program.(Brief Article)
September 23, 2002... 2002 SEP 23 - (NewsRx.com & NewsRx.net) -- Roche and Trimeris (TRMS) announced that physician enrollment for the U.S. early-access program for Fuzeon (enfuvirtide), formerly known as T-20, opened on August 19, 2002. This program, running...

Triangle Pharmaceuticals names Daniel G. Welch chairman and CEO.(Brief Article)
September 23, 2002... 2002 SEP 23 - (NewsRx.com & NewsRx.net) -- Triangle Pharmaceuticals, Inc., (VIRS) announced that Daniel G. Welch has been appointed chairman and CEO effective August 5, 2002. Welch succeeds Dr. David Barry, founder and former chief...

VaxGen joint venture to buy 24 acres in South Korea.(Brief Article)
September 23, 2002... 2002 SEP 23 - (NewsRx.com & NewsRx.net) -- VaxGen, Inc., (VXGN) announced that its biopharmaceutical manufacturing joint venture, Celltrion, Inc., has secured the purchase of 24-acres of land in Incheon, South Korea, for the site of its major...

ViroLogic: Data on increase in HIV drug resistance published.
September 23, 2002... 2002 SEP 23 - (NewsRx.com & NewsRx.net) -- ViroLogic, Inc., (VLGC) announced that the spread of drug-resistant HIV has accelerated rapidly over the last several years according to research using its technology and published in the New England...

Antiviral-focused company announces second quarter 2002 financial results.(ViroLogic, Inc.)
September 23, 2002... 2002 SEP 23 - (NewsRx.com & NewsRx.net) -- ViroLogic, Inc., (VLGC) reported financial results for the second quarter ended June 30, 2002. The company reported revenue of $6.7 million for the second quarter, up 40% over revenue of $4.8...

Revenues increase 18.2% for infectious disease detection and monitoring company.(Boston Biomedica, Inc.)
September 23, 2002... 2002 SEP 23 - (NewsRx.com & NewsRx.net) -- Boston Biomedica, Inc., which provides products and services for the detection and monitoring of infectious diseases such as AIDS and viral hepatitis, announced that revenue from continuing operations...

Second quarter 2002 financial results reported by gene, cell therapy technology.
September 23, 2002... 2002 SEP 23 - (NewsRx.com & NewsRx.net) -- Targeted Genetics Corp. (TGEN) announced that for the quarter ended June 30, 2002, it reported a net loss of $6.4 million compared with $5.9 million for the second quarter of 2001. Net loss per...

Improved HIV viral load test approved by FDA.
September 23, 2002... 2002 SEP 23 - (NewsRx.com & NewsRx.net) -- Roche Diagnostics announced that it has received marketing approval from the U.S. Food and Drug Administration (FDA) for the Roche Amplicor HIV-1 Monitor Test, version 1.5. This test is a highly...

Abacavir substitution has limited benefits for lipoatrophy patients.
September 23, 2002... 2002 SEP 23 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in Australia say that substituting abacavir for other antiretroviral agents can help patients with HIV-related metabolic dysfunction although the...

Pediatric antiretroviral treatment should target nervous system infection.
September 23, 2002... 2002 SEP 23 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Treatment regimens for HIV+ children should include agents that affect central nervous system (CNS) infection, researchers argue. Cynthia McCoig and...

Sunesis receives NIH grant to develop new HIV therapies.(National Institutes of Health)
September 23, 2002... 2002 SEP 23 - (NewsRx.com & NewsRx.net) -- Sunesis Pharmaceuticals, Inc., announced that the company has been granted a $600,000, 2-year phase I Small Business Innovative Research grant from the National Institute of Allergy and Infectious...

Company achieves research breakthrough using tethering technology.(Sunesis Pharmaceuticals, Inc.)
September 23, 2002... 2002 SEP 23 - (NewsRx.com & NewsRx.net) -- Sunesis Pharmaceuticals, Inc., announced the discovery of a potent, small molecule inhibitor of interleukin-2 (IL-2), providing the most advanced proof of principle to date of the company's "tethering"...

Thai hospital claims reduced mother-baby transmission.(Brief Article)
September 23, 2002... 2002 SEP 23 - (NewsRx.com & NewsRx.net) -- A Bangkok hospital says it has cut the rate of HIV transmission from pregnant mothers to their unborn children using a drug cocktail rather than a single antiretroviral dosage. The government-run...

Operational changes announced.(Targeted Genetics Corp.)
September 23, 2002... 2002 SEP 23 - (NewsRx.com & NewsRx.net) -- Targeted Genetics Corp. (GEN) announced that it is restructuring its operations to reduce expenses and concentrate its resources on key product development programs and continuing business development...

gag-based DNA vaccine effective in primates.
September 30, 2002... 2002 SEP 30 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - An HIV DNA vaccine can produce sustained and effective cell-mediated immune responses to the virus in animals, researchers in the United States report. ...

Vertically infected children suffer from cardiovascular dysfunction.
September 30, 2002... 2002 SEP 30 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Children vertically infected with HIV are likely to suffer from impaired cardiac function, researchers in the United States warn. "Data from...

Amprenavir prodrug can reduce pill burden.
September 30, 2002... 2002 SEP 30 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in the United Kingdom may have found a way to reduce HIV patients' pill burden during some antiretroviral drug regimens. C. Falcoz and...

Chicago researchers find why uncircumcised men have more HIV.
September 30, 2002... 2002 SEP 30 - (NewsRx.com & NewsRx.net) -- A new study conducted by Chicago researchers shows that internal mucosal layers of foreskin are more susceptible to HIV infection than cervical tissue or the external layers of foreskin, which explains...

Kidney transplants available to HIV-positive patients.
September 30, 2002... 2002 SEP 30 - (NewsRx.com & NewsRx.net) -- HIV-positive patients may be eligible for kidney transplants despite the fact they have the virus that causes AIDS. Due to therapeutic advances in HIV/AIDS care, those with the AIDS virus now can...

Triangle announces reacquisition of product rights from Abbott.(Triangle Pharmaceuticals Inc.)
September 30, 2002... 2002 SEP 30 - (NewsRx.com & NewsRx.net) -- Triangle Pharmaceuticals, Inc., (VIRS) announced that it has reacquired from Abbott Laboratories (ABT) full product rights, including rights to all profits, for four drug candidates in clinical...

HIV medication adherence worsens following September 11 attacks.
September 30, 2002... 2002 SEP 30 - (NewsRx.com & NewsRx.net) -- Gay and bisexual men with HIV on HAART (highly active antiretroviral therapy) were more likely to have missed more doses or taken them later after September 11 than they were before, according to a...

Molecular HIV/HCV screen fast, accurate.(hepatitis C virus)
September 30, 2002... 2002 SEP 30 - (NewsRx.com & NewsRx.net) -- by Michael Greer, senior medical writer - Researchers in the United States say that a nucleic acid test can quickly and accurately find HIV and hepatitis C virus (HCV) in donated blood. Janet...

Mymetics registration statement effective.(Brief Article)
September 30, 2002... 2002 SEP 30 - (NewsRx.com & NewsRx.net) -- Mymetics, Inc., (MYMX) announced that its registration statement on form S1 filed with the Securities and Exchange Commission has become effective, thereby registering the sale of up to 48,487,487...